Frontiers in Molecular Biosciences
November 22, 2022

Publication: Principles and functions of condensate modifying drugs

A new perspective on the principles and functions of condensate modifying drugs (c-mods) was published in Frontiers in Molecular Biosciences.

The article co-authored by Dewpoint scientists, proposed that understanding mechanisms of condensate perturbation of known c-mods will accelerate the discovery of a new class of therapies for difficult-to-treat diseases. This article adds to a growing body of evidence on the importance of condensate modification. 

You can read the full article published on

Media Contact

Jeanette Bressi
VP, Head of Communications & PR
Dewpoint Therapeutics
+1 609-439-3997 |

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science